Positive nuclear staining for MLH1 and MSH2 antibodies were detected in tumor sections of 54 (70%) patients (MSS group); in 24 (30%), negative nuclear staining for MLH1 but positive for MSH2 was detected (MLH1 related MSI-H group). This evidence concerns the gene MSH2 and neoplasm.